Bentley University

Study: Biotech no riskier for investors

Bentley University, BioPharma, biotech IPO, Daily, Massachusetts, News, Startups, SYN, Top Story / January 21, 2021 January 21, 2021

Despite lower sales, lack of profits and heavy R&D spending, biotech companies that went public between 1997 and 2016 reached similar market caps as non-biotech companies, according to an academic study.

Gilead Covid-19 drug remdesivir benefited from $6.5B in NIH-funded basic research, study finds

Bentley University, BioPharma, biopharma nl, California, Center for Integration of Science and Industry, coronavirus, drug pricing, Foster City, Gilead Sciences, remdesivir. Covid-19, SARS-CoV-2, SYN, Top Story / July 10, 2020 July 10, 2020

Research on the drug’s molecular target dates back to the 1950s. A spokesperson for Gilead noted that the company anticipates potentially investing more than $1 billion on the drug this year alone.